Supplement to Structure and function of nucleotide sugar transporters.
补充核苷酸糖转运蛋白的结构和功能。
基本信息
- 批准号:10798026
- 负责人:
- 金额:$ 3.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressBackBindingBiochemicalBiological AssayComplexCrystallizationCytidine Monophosphate N-Acetylneuraminic AcidCytoplasmDiseaseEukaryotaGenesGlycoconjugatesGoalsGolgi ApparatusLipidsMethodsMolecularMusMutationNeoplasm MetastasisNucleotidesParasitesPathogenicityPatternPhysiologicalPhysiologyPlayProtein FamilyProtein GlycosylationReactionResolutionRoleStructureStructure-Activity RelationshipTherapeuticTumor PromotionVirulencedrug developmentglycosylationglycosyltransferasenovelnovel therapeutic interventionsialic acid permeasesugar nucleotidetumor
项目摘要
Project summary (from original application)
Nucleotide sugar transporters (NSTs) are a family of proteins that are a critical part of the glycosylation
machinery in all eukaryotes as they are responsible for transporting nucleotide sugars from the cytoplasm,
where they are synthesized, into the Golgi lumen where they are then utilized by glycosyltransferases to
glycosylate proteins and lipids. NSTs provide an additional essential role of transporting the nucleotide
monophosphate byproduct of the glycosyltransferase reaction, which is inhibitory towards
glycosyltransferases, back to the cytoplasm where it can be recycled. Since NST activity controls the
concentrations of both nucleotide sugars and nucleotide monophosphates in the Golgi lumen, disruption of
NST activity can have many adverse physiological effects as is seen in a number of diseases caused by
either mutations in NST genes or dysregulation of NST activity. However, selective inhibition of NSTs also
has the potential to be exploited for therapeutic benefit in targeting parasites that depend on particular
glycoconjugates for virulence as well as in blocking certain glycosylation patterns that promote tumor
metastasis. Our long-term goal is to understand the molecular details that underlie substrate recognition,
substrate selectivity, and the mechanism of transport of NSTs. Although NSTs were first described nearly
four decades ago, many of these questions remain largely unanswered, primarily due to a lack of structural
information for NSTs as well as limited methods for biochemical characterization of this family of proteins. To
overcome these obstacles, we have developed methods to express, purify, and crystallize a mammalian
NST, the mouse CMP-sialic acid transporter (CST). We have also developed novel binding and transport
assays that will allow us to address questions regarding substrate recognition and selectivity. These methods
will allow us to determine high- resolution structures of CST in complex with its substrates CMP and CMP-
sialic acid, as well as structures that represent different states of the transport cycle. These structures
combined with biochemical studies will answer the fundamental questions regarding the structure-function
relationship of NSTs, which will further our understanding of the role NSTs play in physiology and aid in the
development of drugs to target NSTs.
项目摘要(来自原始申请)
核苷酸糖转运蛋白(NSTs)是一类在糖基化过程中起重要作用的蛋白质家族
所有真核生物中的机器,因为它们负责从细胞质运输核苷酸糖,
在那里它们被合成,进入高尔基体腔,然后在那里它们被糖基转移酶利用,
糖基化蛋白质和脂质。NST提供了转运核苷酸的额外重要作用
糖基转移酶反应的单磷酸副产物,其抑制糖基转移酶反应。
糖基转移酶,回到细胞质,在那里它可以回收。由于NST活动控制着
浓度的核苷酸糖和核苷酸单磷酸在高尔基体腔,破坏
NST活性可具有许多不利的生理作用,如在由NST引起的许多疾病中所见。
NST基因突变或NST活性失调。然而,选择性抑制NST也
有可能被开发用于靶向依赖于特定的寄生虫的治疗益处,
糖缀合物的毒性以及阻断某些促进肿瘤的糖基化模式
转移我们的长期目标是了解底物识别的分子细节,
底物选择性和NST的转运机制。尽管NST最初被描述为
40年前,这些问题中的许多问题在很大程度上仍然没有答案,主要是由于缺乏结构性的
NST的信息以及用于该蛋白质家族的生物化学表征的有限方法。到
克服这些障碍,我们已经开发出表达、纯化和结晶哺乳动物细胞的方法,
NST,小鼠CMP-唾液酸转运蛋白(CST)。我们还开发了新的绑定和传输
这将使我们能够解决有关底物识别和选择性的问题。这些方法
将使我们能够确定高分辨率结构的CST在复杂的与其基板CMP和CMP-
唾液酸,以及代表运输循环不同状态的结构。这些结构
结合生物化学研究将回答有关结构-功能的基本问题,
NST的关系,这将进一步加深我们对NST在生理学中的作用的理解,并有助于
开发针对NST的药物。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Inhibition of CMP-sialic acid transport by endogenous 5-methyl CMP.
- DOI:10.1371/journal.pone.0249905
- 发表时间:2021
- 期刊:
- 影响因子:3.7
- 作者:Ahuja S;Cahill J;Hartfield K;Whorton MR
- 通讯作者:Whorton MR
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Isabelle Rhyssa Joe Eduria Baconguis其他文献
Isabelle Rhyssa Joe Eduria Baconguis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Isabelle Rhyssa Joe Eduria Baconguis', 18)}}的其他基金
Elucidating the molecular mechanism of ENaC function
阐明 ENaC 功能的分子机制
- 批准号:
10593943 - 财政年份:2020
- 资助金额:
$ 3.05万 - 项目类别:
Elucidating the molecular mechanism of ENaC function
阐明 ENaC 功能的分子机制
- 批准号:
10390185 - 财政年份:2020
- 资助金额:
$ 3.05万 - 项目类别:
Elucidating the molecular mechanism of ENaC function
阐明 ENaC 功能的分子机制
- 批准号:
10379425 - 财政年份:2020
- 资助金额:
$ 3.05万 - 项目类别:
Elucidating the molecular mechanism of ENaC function
阐明 ENaC 功能的分子机制
- 批准号:
10176541 - 财政年份:2020
- 资助金额:
$ 3.05万 - 项目类别:
Elucidating the molecular mechanism of ENaC function
阐明 ENaC 功能的分子机制
- 批准号:
10029325 - 财政年份:2020
- 资助金额:
$ 3.05万 - 项目类别:
Structure and function of nucleotide sugar transporters.
核苷酸糖转运蛋白的结构和功能。
- 批准号:
10375458 - 财政年份:2019
- 资助金额:
$ 3.05万 - 项目类别:
Structure and function of nucleotide sugar transporters.
核苷酸糖转运蛋白的结构和功能。
- 批准号:
9898414 - 财政年份:2019
- 资助金额:
$ 3.05万 - 项目类别:
Structure and function of nucleotide sugar transporters.
核苷酸糖转运蛋白的结构和功能。
- 批准号:
10595005 - 财政年份:2019
- 资助金额:
$ 3.05万 - 项目类别:
Structure and Function of Epithelial Sodium Channels
上皮钠通道的结构和功能
- 批准号:
8918334 - 财政年份:2013
- 资助金额:
$ 3.05万 - 项目类别:
Structure and Function of Epithelial Sodium Channels
上皮钠通道的结构和功能
- 批准号:
9349364 - 财政年份:2013
- 资助金额:
$ 3.05万 - 项目类别:
相似国自然基金
基于Teach-back药学科普模式的慢阻肺患者吸入用药依从性及疗效研究
- 批准号:2024KP61
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Quench-Back保护的超导螺线管磁体失超过程数值模拟研究
- 批准号:51307073
- 批准年份:2013
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
CAREER: From Dynamic Algorithms to Fast Optimization and Back
职业:从动态算法到快速优化并返回
- 批准号:
2338816 - 财政年份:2024
- 资助金额:
$ 3.05万 - 项目类别:
Continuing Grant
One-step reconstruction of plastic waste back to its constituent monomers (ONESTEP)
将塑料废物一步重建回其组成单体(ONESTEP)
- 批准号:
EP/Y003934/1 - 财政年份:2024
- 资助金额:
$ 3.05万 - 项目类别:
Research Grant
On the origin of very massive back holes
关于巨大背洞的起源
- 批准号:
DP240101786 - 财政年份:2024
- 资助金额:
$ 3.05万 - 项目类别:
Discovery Projects
Back to our roots: Re-activating Indigenous biocultural conservation
回到我们的根源:重新激活本土生物文化保护
- 批准号:
FT230100595 - 财政年份:2024
- 资助金额:
$ 3.05万 - 项目类别:
ARC Future Fellowships
Collaborative Research: NSFGEO-NERC: MEZCAL: Methods for Extending the horiZontal Coverage of the Amoc Latitudinally and back in time (MEZCAL)
合作研究:NSFGEO-NERC:MEZCAL:扩展 Amoc 纬度和时间回水平覆盖范围的方法 (MEZCAL)
- 批准号:
2409764 - 财政年份:2023
- 资助金额:
$ 3.05万 - 项目类别:
Standard Grant
Collaborative Research: FuSe: Indium selenides based back end of line neuromorphic accelerators
合作研究:FuSe:基于硒化铟的后端神经形态加速器
- 批准号:
2328741 - 财政年份:2023
- 资助金额:
$ 3.05万 - 项目类别:
Continuing Grant
Brain Mechanisms of Chronic Low-Back Pain: Specificity and Effects of Aging and Sex
慢性腰痛的脑机制:衰老和性别的特异性和影响
- 批准号:
10657958 - 财政年份:2023
- 资助金额:
$ 3.05万 - 项目类别:
The Role of VEGF in the Development of Low Back Pain Following IVD Injury
VEGF 在 IVD 损伤后腰痛发展中的作用
- 批准号:
10668079 - 财政年份:2023
- 资助金额:
$ 3.05万 - 项目类别:
Relationships Between Pain-Related Psychological Factors, Gait Quality, and Attention in Chronic Low Back Pain
慢性腰痛中疼痛相关心理因素、步态质量和注意力之间的关系
- 批准号:
10679189 - 财政年份:2023
- 资助金额:
$ 3.05万 - 项目类别:
Psilocybin and Affective Function in Chronic Lower Back Pain and Depression
裸盖菇素与慢性腰痛和抑郁症的情感功能
- 批准号:
10626449 - 财政年份:2023
- 资助金额:
$ 3.05万 - 项目类别: